Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Validating risk prediction models for multiple primaries and competing cancer outcomes in families with Li-Fraumeni syndrome using clinically ascertained data at a single institute

Nam H. Nguyen, Elissa B. Dodd-Eaton, Jessica L. Corredor, Jacynda Woodman-Ross, Sierra Green, Nathaniel D. Hernandez, Angelica M. Gutierrez Barrera, Banu K. Arun, View ORCID ProfileWenyi Wang
doi: https://doi.org/10.1101/2023.08.31.23294849
Nam H. Nguyen
1The University of Texas MD Anderson Cancer Center, Department of Bioinformatics and Computation Biology, Houston, TX
2Rice University, Department of Statistics, Houston, TX
MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elissa B. Dodd-Eaton
1The University of Texas MD Anderson Cancer Center, Department of Bioinformatics and Computation Biology, Houston, TX
MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jessica L. Corredor
3The University of Texas MD Anderson Cancer Center, Department of Clinical Cancer Genetics, Houston, TX
MS, CGC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jacynda Woodman-Ross
3The University of Texas MD Anderson Cancer Center, Department of Clinical Cancer Genetics, Houston, TX
MS, CGC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sierra Green
3The University of Texas MD Anderson Cancer Center, Department of Clinical Cancer Genetics, Houston, TX
BS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nathaniel D. Hernandez
3The University of Texas MD Anderson Cancer Center, Department of Clinical Cancer Genetics, Houston, TX
BS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Angelica M. Gutierrez Barrera
4The University of Texas MD Anderson Cancer Center, Department of Breast Medical Oncology, Houston, TX
MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Banu K. Arun
4The University of Texas MD Anderson Cancer Center, Department of Breast Medical Oncology, Houston, TX
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wenyi Wang
1The University of Texas MD Anderson Cancer Center, Department of Bioinformatics and Computation Biology, Houston, TX
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Wenyi Wang
  • For correspondence: wwang7{at}mdanderson.org
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Article Information

doi 
https://doi.org/10.1101/2023.08.31.23294849
History 
  • September 2, 2023.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Nam H. Nguyen, MS1,2,
  2. Elissa B. Dodd-Eaton, MPH1,
  3. Jessica L. Corredor, MS, CGC3,
  4. Jacynda Woodman-Ross, MS, CGC3,
  5. Sierra Green, BS3,
  6. Nathaniel D. Hernandez, BS3,
  7. Angelica M. Gutierrez Barrera, MS4,
  8. Banu K. Arun, MD4 and
  9. Wenyi Wang, PhD1,*
  1. 1The University of Texas MD Anderson Cancer Center, Department of Bioinformatics and Computation Biology, Houston, TX
  2. 2Rice University, Department of Statistics, Houston, TX
  3. 3The University of Texas MD Anderson Cancer Center, Department of Clinical Cancer Genetics, Houston, TX
  4. 4The University of Texas MD Anderson Cancer Center, Department of Breast Medical Oncology, Houston, TX
  1. ↵*Corresponding author: Wenyi Wang, PhD; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Houston, TX 77030; email: wwang7{at}mdanderson.org.
Back to top
PreviousNext
Posted September 02, 2023.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Validating risk prediction models for multiple primaries and competing cancer outcomes in families with Li-Fraumeni syndrome using clinically ascertained data at a single institute
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Validating risk prediction models for multiple primaries and competing cancer outcomes in families with Li-Fraumeni syndrome using clinically ascertained data at a single institute
Nam H. Nguyen, Elissa B. Dodd-Eaton, Jessica L. Corredor, Jacynda Woodman-Ross, Sierra Green, Nathaniel D. Hernandez, Angelica M. Gutierrez Barrera, Banu K. Arun, Wenyi Wang
medRxiv 2023.08.31.23294849; doi: https://doi.org/10.1101/2023.08.31.23294849
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Validating risk prediction models for multiple primaries and competing cancer outcomes in families with Li-Fraumeni syndrome using clinically ascertained data at a single institute
Nam H. Nguyen, Elissa B. Dodd-Eaton, Jessica L. Corredor, Jacynda Woodman-Ross, Sierra Green, Nathaniel D. Hernandez, Angelica M. Gutierrez Barrera, Banu K. Arun, Wenyi Wang
medRxiv 2023.08.31.23294849; doi: https://doi.org/10.1101/2023.08.31.23294849

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Oncology
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)